$EBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Emergent BioSolutions Inc.. Get notifications about new insider transactions in Emergent BioSolutions Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 21 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 15.91 | 3,467 | 55,160 | 0 | |
Mar 31 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 15.91 | 3,467 | 55,160 | 40,972 | 37.5 K to 41 K (+9.24 %) |
Mar 16 2016 | EBS | Emergent BioSoluti ... | Hauer Jerome M | Director | Sell | S | 33.88 | 2,350 | 79,618 | 14,100 | 16.5 K to 14.1 K (-14.29 %) |
Mar 16 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 33.96 | 1,658 | 56,306 | 37,505 | 39.2 K to 37.5 K (-4.23 %) |
Mar 16 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 33.96 | 2,701 | 91,726 | 39,163 | 41.9 K to 39.2 K (-6.45 %) |
Mar 15 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 14.67 | 7,960 | 116,773 | 0 | |
Mar 15 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 34.22 | 1,278 | 43,733 | 41,864 | 43.1 K to 41.9 K (-2.96 %) |
Mar 15 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 33.84 | 3,152 | 106,664 | 43,142 | 46.3 K to 43.1 K (-6.81 %) |
Mar 15 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 33.84 | 7,960 | 269,366 | 46,294 | 54.3 K to 46.3 K (-14.67 %) |
Mar 15 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 14.67 | 7,960 | 116,773 | 54,254 | 46.3 K to 54.3 K (+17.19 %) |
Mar 15 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 6,967 | 0 | 69,196 | |
Mar 15 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 34.22 | 1,902 | 65,086 | 1,799,073 | 1.8 M to 1.8 M (-0.11 %) |
Mar 15 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 6,967 | 0 | 1,800,975 | 1.8 M to 1.8 M (+0.39 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 14,879 | 152,956 | 0 | |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 34.03 | 14,879 | 506,332 | 28,500 | 43.4 K to 28.5 K (-34.30 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 14,879 | 152,956 | 43,379 | 28.5 K to 43.4 K (+52.21 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 14,820 | 152,350 | 14,879 | |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 35.34 | 14,820 | 523,739 | 28,500 | 43.3 K to 28.5 K (-34.21 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 14,820 | 152,350 | 43,320 | 28.5 K to 43.3 K (+52.00 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Payment of Exercise | F | 34.38 | 2,786 | 95,783 | 80,077 | 82.9 K to 80.1 K (-3.36 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Payment of Exercise | F | 34.60 | 1,796 | 62,142 | 82,863 | 84.7 K to 82.9 K (-2.12 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 34.38 | 1,480 | 50,882 | 46,294 | 47.8 K to 46.3 K (-3.10 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Payment of Exercise | F | 34.60 | 1,061 | 36,711 | 47,774 | 48.8 K to 47.8 K (-2.17 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 34.38 | 9,794 | 336,718 | 203,561 | 213.4 K to 203.6 K (-4.59 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 34.60 | 7,484 | 258,946 | 213,355 | 220.8 K to 213.4 K (-3.39 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 18,746 | 0 | 76,163 | |
Mar 11 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 0.00 | 12,073 | 0 | 94,909 | |
Mar 11 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 34.38 | 5,128 | 176,301 | 1,794,008 | 1.8 M to 1.8 M (-0.29 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 18,746 | 0 | 1,799,136 | 1.8 M to 1.8 M (+1.05 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Payment of Exercise | F | 34.60 | 3,288 | 113,765 | 1,780,390 | 1.8 M to 1.8 M (-0.18 %) |
Mar 11 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 0.00 | 12,073 | 0 | 1,783,678 | 1.8 M to 1.8 M (+0.68 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | M | 20.44 | 3,134 | 64,059 | 6,266 | |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | M | 14.25 | 4,800 | 68,400 | 2,400 | |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | M | 14.66 | 7,200 | 105,552 | 0 | |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | M | 22.02 | 7,200 | 158,544 | 0 | |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Option Exercise | M | 15.75 | 10,800 | 170,100 | 0 | |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Sell | S | 35.42 | 3,134 | 111,006 | 30,300 | 33.4 K to 30.3 K (-9.37 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Buy | M | 20.44 | 3,134 | 64,059 | 33,434 | 30.3 K to 33.4 K (+10.34 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Sell | S | 35.42 | 4,800 | 170,016 | 30,300 | 35.1 K to 30.3 K (-13.68 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Buy | M | 14.25 | 4,800 | 68,400 | 35,100 | 30.3 K to 35.1 K (+15.84 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Sell | S | 35.42 | 7,200 | 255,024 | 30,300 | 37.5 K to 30.3 K (-19.20 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Buy | M | 14.66 | 7,200 | 105,552 | 37,500 | 30.3 K to 37.5 K (+23.76 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Sell | S | 35.42 | 7,200 | 255,024 | 30,300 | 37.5 K to 30.3 K (-19.20 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Buy | M | 22.02 | 7,200 | 158,544 | 37,500 | 30.3 K to 37.5 K (+23.76 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Sell | S | 35.42 | 10,800 | 382,536 | 30,300 | 41.1 K to 30.3 K (-26.28 %) |
Mar 09 2016 | EBS | Emergent BioSoluti ... | White Marvin L | Director | Buy | M | 15.75 | 10,800 | 170,100 | 41,100 | 30.3 K to 41.1 K (+35.64 %) |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | A | 33.83 | 15,514 | 524,839 | 15,514 | |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Grant | A | 0.00 | 7,759 | 0 | 48,835 | 41.1 K to 48.8 K (+18.89 %) |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Option Exercise | A | 33.83 | 29,550 | 999,677 | 29,550 | |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Grant | A | 0.00 | 14,780 | 0 | 84,659 | 69.9 K to 84.7 K (+21.15 %) |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | A | 33.83 | 70,922 | 2,399,291 | 70,922 | |
Mar 03 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Grant | A | 0.00 | 35,471 | 0 | 220,839 | 185.4 K to 220.8 K (+19.14 %) |
Mar 03 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 33.83 | 53,192 | 1,799,485 | 53,192 | |
Mar 03 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Grant | A | 0.00 | 26,303 | 0 | 1,797,908 | 1.8 M to 1.8 M (+1.48 %) |
Apr 25 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.50 | 4,209 | 170,465 | 1,724,073 | 1.7 M to 1.7 M (-0.24 %) |
Apr 20 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 40.50 | 20,791 | 842,036 | 1,728,282 | 1.7 M to 1.7 M (-1.19 %) |
Apr 20 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 40.17 | 2,373 | 95,323 | 188,366 | 190.7 K to 188.4 K (-1.24 %) |
Apr 20 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 40.17 | 3,580 | 143,809 | 190,739 | 194.3 K to 190.7 K (-1.84 %) |
Apr 20 2016 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 40.17 | 2,749 | 110,427 | 194,319 | 197.1 K to 194.3 K (-1.39 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Option Exercise | M | 29.00 | 2,751 | 79,779 | 22,011 | |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Option Exercise | M | 28.09 | 8,677 | 243,737 | 17,354 | |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Option Exercise | M | 14.67 | 1,970 | 28,900 | 0 | |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Option Exercise | M | 14.41 | 5,765 | 83,074 | 0 | |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Sell | S | 38.90 | 2,623 | 102,035 | 69,163 | 71.8 K to 69.2 K (-3.65 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Sell | S | 38.90 | 2,751 | 107,014 | 71,786 | 74.5 K to 71.8 K (-3.69 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Buy | M | 29.00 | 2,751 | 79,779 | 74,537 | 71.8 K to 74.5 K (+3.83 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Sell | S | 38.90 | 8,677 | 337,535 | 71,786 | 80.5 K to 71.8 K (-10.78 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Buy | M | 28.09 | 8,677 | 243,737 | 80,463 | 71.8 K to 80.5 K (+12.09 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Sell | S | 38.90 | 1,970 | 76,633 | 71,786 | 73.8 K to 71.8 K (-2.67 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Buy | M | 14.67 | 1,970 | 28,900 | 73,756 | 71.8 K to 73.8 K (+2.74 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Sell | S | 38.90 | 5,765 | 224,259 | 71,786 | 77.6 K to 71.8 K (-7.43 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Buy | M | 14.41 | 5,765 | 83,074 | 77,551 | 71.8 K to 77.6 K (+8.03 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 39.50 | 25,000 | 987,500 | 1,749,073 | 1.8 M to 1.7 M (-1.41 %) |
Apr 08 2016 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 38.50 | 25,000 | 962,500 | 1,774,073 | 1.8 M to 1.8 M (-1.39 %) |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 22.02 | 2,880 | 63,418 | 4,320 | |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 16.13 | 2,880 | 46,454 | 2,880 | |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 11.67 | 5,760 | 67,219 | 2,880 | |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 38.46 | 2,880 | 110,765 | 28,500 | 31.4 K to 28.5 K (-9.18 %) |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 22.02 | 2,880 | 63,418 | 31,380 | 28.5 K to 31.4 K (+10.11 %) |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 38.77 | 2,880 | 111,658 | 28,500 | 31.4 K to 28.5 K (-9.18 %) |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 16.13 | 2,880 | 46,454 | 31,380 | 28.5 K to 31.4 K (+10.11 %) |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 38.97 | 5,760 | 224,467 | 28,500 | 34.3 K to 28.5 K (-16.81 %) |
Jan 06 2016 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 11.67 | 5,760 | 67,219 | 34,260 | 28.5 K to 34.3 K (+20.21 %) |
Jan 04 2016 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Option Exercise | M | 8.43 | 21,600 | 182,088 | 0 | |
Jan 04 2016 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 40.00 | 21,600 | 864,000 | 13,733 | 35.3 K to 13.7 K (-61.13 %) |
Jan 04 2016 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Buy | M | 8.43 | 21,600 | 182,088 | 35,333 | 13.7 K to 35.3 K (+157.29 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 18.90 | 22,855 | 431,960 | 0 | |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 18.90 | 40,354 | 762,691 | 22,855 | |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 39.17 | 22,855 | 895,230 | 185,368 | 208.2 K to 185.4 K (-10.98 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 18.90 | 22,855 | 431,960 | 208,223 | 185.4 K to 208.2 K (+12.33 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Sell | S | 38.99 | 40,354 | 1,573,402 | 185,368 | 225.7 K to 185.4 K (-17.88 %) |
Dec 28 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 18.90 | 40,354 | 762,691 | 225,722 | 185.4 K to 225.7 K (+21.77 %) |
Dec 17 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Option Exercise | M | 24.15 | 4,140 | 99,981 | 37,860 | |
Dec 17 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Payment of Exercise | F | 37.87 | 2,641 | 100,015 | 185,368 | 188 K to 185.4 K (-1.40 %) |
Dec 17 2015 | EBS | Emergent BioSoluti ... | Abdun-Nabi Daniel | President & CEO | Buy | M | 24.15 | 4,140 | 99,981 | 188,009 | 183.9 K to 188 K (+2.25 %) |
Nov 19 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 18.90 | 27,900 | 527,310 | 0 | |
Nov 19 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 37.50 | 17,871 | 670,163 | 1,852,284 | 1.9 M to 1.9 M (-0.96 %) |
Nov 19 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 18.90 | 27,900 | 527,310 | 1,870,155 | 1.8 M to 1.9 M (+1.51 %) |
Nov 17 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.50 | 3,376 | 123,224 | 25,182 | 28.6 K to 25.2 K (-11.82 %) |
Nov 16 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 18.90 | 20,000 | 378,000 | 27,900 | |
Nov 16 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 36.50 | 13,013 | 474,975 | 1,842,255 | 1.9 M to 1.8 M (-0.70 %) |
Nov 16 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 18.90 | 20,000 | 378,000 | 1,855,268 | 1.8 M to 1.9 M (+1.09 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,094 | 211,368 | 0 | |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,095 | 211,389 | 0 | |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 28.09 | 9,373 | 263,288 | 0 | |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 35.88 | 1,671 | 59,955 | 28,558 | 30.2 K to 28.6 K (-5.53 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.00 | 10,094 | 363,384 | 30,229 | 40.3 K to 30.2 K (-25.03 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 20.94 | 10,094 | 211,368 | 40,323 | 30.2 K to 40.3 K (+33.39 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.50 | 10,095 | 358,373 | 30,229 | 40.3 K to 30.2 K (-25.03 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 20.94 | 10,095 | 211,389 | 40,324 | 30.2 K to 40.3 K (+33.40 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.50 | 9,373 | 332,742 | 30,229 | 39.6 K to 30.2 K (-23.67 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Buy | M | 28.09 | 9,373 | 263,288 | 39,602 | 30.2 K to 39.6 K (+31.01 %) |
Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 35.51 | 6,564 | 233,088 | 30,229 | 36.8 K to 30.2 K (-17.84 %) |
Nov 10 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 18.90 | 20,000 | 378,000 | 47,900 | |
Nov 10 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 35.50 | 13,225 | 469,488 | 1,835,268 | 1.8 M to 1.8 M (-0.72 %) |
Nov 10 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 18.90 | 20,000 | 378,000 | 1,848,493 | 1.8 M to 1.8 M (+1.09 %) |
Nov 06 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 18.90 | 20,000 | 378,000 | 67,900 | |
Nov 06 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 34.50 | 13,450 | 464,025 | 1,828,493 | 1.8 M to 1.8 M (-0.73 %) |
Nov 06 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 18.90 | 20,000 | 378,000 | 1,841,943 | 1.8 M to 1.8 M (+1.10 %) |
Nov 06 2015 | EBS | Emergent BioSoluti ... | Kramer Robert | EVP, Corporate Serv ... | Payment of Exercise | F | 33.53 | 1,234 | 41,376 | 69,879 | 71.1 K to 69.9 K (-1.74 %) |
Nov 04 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | M | 18.90 | 20,000 | 378,000 | 87,900 | |
Nov 04 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 33.50 | 13,689 | 458,582 | 1,821,943 | 1.8 M to 1.8 M (-0.75 %) |
Nov 04 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Buy | M | 18.90 | 20,000 | 378,000 | 1,835,632 | 1.8 M to 1.8 M (+1.10 %) |
Sep 15 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 8.76 | 4,640 | 40,646 | 0 | |
Sep 15 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Option Exercise | M | 8.43 | 1,440 | 12,139 | 0 | |
Sep 15 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 32.33 | 4,640 | 150,011 | 28,500 | 33.1 K to 28.5 K (-14.00 %) |
Sep 15 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 8.76 | 4,640 | 40,646 | 33,140 | 28.5 K to 33.1 K (+16.28 %) |
Sep 15 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 32.49 | 1,440 | 46,786 | 28,500 | 29.9 K to 28.5 K (-4.81 %) |
Sep 15 2015 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Buy | M | 8.43 | 1,440 | 12,139 | 29,940 | 28.5 K to 29.9 K (+5.05 %) |
Aug 14 2015 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Option Exercise | M | 17.51 | 7,200 | 126,072 | 3,600 | |
Aug 14 2015 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Sell | S | 34.72 | 7,200 | 249,984 | 19,500 | 26.7 K to 19.5 K (-26.97 %) |
Aug 14 2015 | EBS | Emergent BioSoluti ... | JOULWAN GEORGE A | Director | Buy | M | 17.51 | 7,200 | 126,072 | 26,700 | 19.5 K to 26.7 K (+36.92 %) |
Aug 13 2015 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 36.00 | 4,922 | 177,192 | 13,733 | 18.7 K to 13.7 K (-26.38 %) |
Aug 10 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 35.50 | 30,000 | 1,065,000 | 1,815,632 | 1.8 M to 1.8 M (-1.63 %) |
Aug 07 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 34.50 | 29,766 | 1,026,927 | 1,845,632 | 1.9 M to 1.8 M (-1.59 %) |
Jul 22 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 34.50 | 234 | 8,073 | 1,875,398 | 1.9 M to 1.9 M (-0.01 %) |
Jul 13 2015 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 34.00 | 4,922 | 167,348 | 18,655 | 23.6 K to 18.7 K (-20.88 %) |
Jul 01 2015 | EBS | Emergent BioSoluti ... | Richard Ronald | Director | Sell | S | 32.76 | 4,923 | 161,277 | 23,577 | 28.5 K to 23.6 K (-17.27 %) |
Jun 26 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 18.90 | 10,238 | 193,498 | 0 | |
Jun 26 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Buy | M | 18.90 | 10,238 | 193,498 | 41,076 | 30.8 K to 41.1 K (+33.20 %) |
Jun 22 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 33.00 | 30,000 | 990,000 | 1,875,632 | 1.9 M to 1.9 M (-1.57 %) |
Jun 22 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 32.50 | 30,000 | 975,000 | 1,905,632 | 1.9 M to 1.9 M (-1.55 %) |
Jun 22 2015 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Sell | S | 32.00 | 14,564 | 466,048 | 1,935,632 | 2 M to 1.9 M (-0.75 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 13,457 | 138,338 | 29,699 | |
Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 31.33 | 13,457 | 421,541 | 28,500 | 42 K to 28.5 K (-32.07 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 13,457 | 138,338 | 41,957 | 28.5 K to 42 K (+47.22 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 15.83 | 9,773 | 154,707 | 0 | |
Jun 17 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Option Exercise | M | 14.67 | 15,919 | 233,532 | 7,960 | |
Jun 17 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 31.50 | 10,606 | 334,110 | 30,838 | 41.4 K to 30.8 K (-25.59 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | Havey Adam | EVP, Biodefense Div ... | Sell | S | 31.67 | 9,773 | 309,462 | 41,444 | 51.2 K to 41.4 K (-19.08 %) |